Abstract

HIV infection greatly increases the risk of developing lymphoma. NHL is present in approximately 3% of the HIV-positive population at the time of their HIV diagnosis. Twenty percent of HIV-positive patients develop NHL. Risk factors for an association of the NHL with HIV include: low CD4 T cell count, high viral load, age, and male.

We report the case of a 35-year-old mother of three children having a history of the death of the husband following the neurological complications of AIDS, the patient was subsequently diagnosed with HIV + and then placed on retroviral treatment. After 6 months the patient reported a breast swelling with pelvic pain, a breast biopsy performed showing a large B-cell NHL.

The extension assessment reveals localizations: mammary, bilateral ovarian and adrenal right of a lymphomatous process, the BOM is normal and the CD4 rate is 517 / mm3. CHOP-type systemic chemotherapy with intrathecal chemotherapy has been initiated. The post-treatment evaluation was in favor of a complete clinical and radiological response.

The prognosis of patients with AIDS-related lymphoma is associated with the stage of the disease, extraganglionic involvement including bone marrow, CD4 cell count, and performance status. Median survival varies from 8 to 20 months, which remains much lower than that of non-HIV-associated lymphomas.

Keywords: large B-cell NHL, breast, CHOP, HIV , Morocco

Downloads

Download data is not yet available.
 How to Cite
Bakraoui, K. E., Ghissassi, I. E., Boutayeb, S., Mrabet, H., & Errihani, H. (2019). CHOP-treated Mammary Non-hodgkin’s Malignant Lymphoma in a Female Patient with HIV + On Retroviral Treatment - Case Report. International Journal of Innovative Research in Medical Science, 4(05), 309 to 311. https://doi.org/10.23958/ijirms/vol04-i05/633

Copyrights & License